Top compounds associated with response to TNFAIP8L2


Feature Type Standardized
Nominal ANOVA
mRNA ATRA CTRPv2 pan-cancer AAC 0.3 1e-13
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.26 2e-10
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 3e-10
mRNA PD318088 CTRPv2 pan-cancer AAC 0.21 2e-07
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 2e-07
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.21 2e-07
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.22 2e-07
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 4e-07
mRNA PF-573228 CTRPv2 pan-cancer AAC 0.2 5e-07
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 1e-06
Download CSV